RISK OF MEMANTINE INITIATION WITH USE OF ANTIMUSCARINICS AND/OR CHOLINESTERASE INHIBITORS IN OLDER ADULTS WITH ALZHEIMER'S DISEASE

被引：0
|
作者：
Chikermane, S. [1 ]
Sherer, J. T. [2 ]
Holmes, H. M. [3 ]
Aparasu, R. R. [2 ]
机构：
[1] Univ Houston, Coll Pharm, Irvine, CA USA
[2] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH163
引用
收藏
页码：S464 / S465
页数：2
相关论文
共 50 条
  • [31] Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
    Susan D Rountree
    Wenyaw Chan
    Valory N Pavlik
    Eveleen J Darby
    Samina Siddiqui
    Rachelle S Doody
    Alzheimers Res Ther, 1
  • [32] Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors
    Talwar, Ashna
    Chatterjee, Satabdi
    Sherer, Jeffrey
    Abughosh, Susan
    Johnson, Michael
    Aparasu, Rajender R.
    DRUGS & AGING, 2024, 41 (04) : 339 - 355
  • [33] CUMULATIVE ANTICHOLINERGIC BURDEN AND ITS PREDICTORS AMONG OLDER ADULTS WITH ALZHEIMER'S DISEASE INITIATING CHOLINESTERASE INHIBITORS
    Talwar, A.
    Sherer, J. T.
    Abughosh, S.
    Chatterjee, S.
    Johnson, M. L.
    Aparasu, R. R.
    VALUE IN HEALTH, 2023, 26 (06) : S53 - S53
  • [34] Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer’s Disease Initiating Cholinesterase Inhibitors
    Ashna Talwar
    Satabdi Chatterjee
    Jeffrey Sherer
    Susan Abughosh
    Michael Johnson
    Rajender R. Aparasu
    Drugs & Aging, 2024, 41 : 339 - 355
  • [35] Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Matsunaga, Shinji
    Kishi, Taro
    Iwata, Nakao
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (05): : 1 - 11
  • [36] Guidelines for the appropriate use of cholinesterase inhibitors in patients with Alzheimer's disease
    Schachter, AS
    Davis, KL
    CNS DRUGS, 1999, 11 (04) : 281 - 288
  • [37] The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
    William James Deardorff
    Eliahu Feen
    George T. Grossberg
    Drugs & Aging, 2015, 32 : 537 - 547
  • [38] Guidelines for the Appropriate Use of Cholinesterase Inhibitors in Patients with Alzheimer’s Disease
    Armand S. Schachter
    Kenneth L. Davis
    CNS Drugs, 1999, 11 : 281 - 288
  • [39] The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease
    Deardorff, William James
    Feen, Eliahu
    Grossberg, George T.
    DRUGS & AGING, 2015, 32 (07) : 537 - 547
  • [40] Prevalence of parkinsonism and other movement disorders in outpatients with Alzheimer's disease using cholinesterase inhibitors and/or memantine
    Munhoz, R. P.
    Teive, H.
    Becker, N.
    Moscovich, M.
    Filla, L.
    Fameli, H.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S108 - S108
12345